CEO/Marketing/Strategy

• Championed the development and execution of international marketing strategies, leading to the successful launch of products across 60 countries. Ensured longevity and market relevance through strategic planning.
• Played a critical role in comprehensive market research initiatives, contributing to the seamless integration of Phenox and Wallaby into the Medtech Europe Neurovascular Tracker.
• Led a significant rebranding initiative for WallabyPhenox, receiving unanimous board approval. This initiative played a key role in strengthening the brand's position in the market.
• Worked closely with Clinical Affairs and Market Access teams to refine clinical claims and develop effective reimbursement strategies, enhancing product credibility and adoption.

Market leader in coronary and peripheral artery disease, EMEA sales $1bn

• Led a dynamic team of 18, overseeing product marketing, communications, and training initiatives.
• Orchestrated the successful repositioning and launch of Xience Sierra, achieving significant market share growth. 136% above expectations, 3% market share increase (28% to 31% in 6 months)
• Formulated therapy development strategies, resulting in a 30% annual revenue surge.
• Exceeding plan by $12m
• Modernized communication channel mix with video and targeted digital content

• Transformed a traditional transactional go-to-market model into a solution selling model.
• Developed and implemented a new business model based on innovative consulting services to obesity centers, driving $12M in incremental annual growth.
• Managed a team of 17 obesity specialists in Europe
• Winner of the 2014 Covidien Innovation Award, Business Model
• Designed and implemented e-health platform with connected device to improve patient journey beforehand after surgery
• Developed partnerships with patient organizations across Europe
• Re-launched European Obesity Day through a pan-European PR campaign with KOLs and patients

• Managed the establishment of DRGs in France, Switzerland, Germany and Italy
• Developed and implemented strategies to accelerate reimbursement for CyberKnife procedures through partnerships with clinicians and national healthcare payers

Led the pricing strategy for the European launch of the TAXUS Drug Eluting Stent, resulting in a 60% market share 6 months after launch.

Manages the distributors for J&J consumer in 25 countries

• Orchestrated the management of distributors across 25 countries, ensuring seamless operations and optimal distribution strategies.
• Spearheaded logistics coordination among 20 different plants worldwide, conducting comprehensive sourcing analyses that culminated in the strategic recommendation of Athens as the global distribution center.
• Led a European task force comprising 10 members, successfully consolidating the production of lip care sticks from five sites to one, resulting in annual cost savings of $1.2 million.
• Innovatively designed and implemented a risk policy for credit management, effectively reducing overdue payments by 20%, equivalent to a value of $5 million.